Journal Home
Search for

Volume 103, Issue 12, Pages 1250-1256 (December 2009)


View previous. 14 of 27 View next.

A cross-sectional study on the clinical and immunological spectrum of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region

José Ângelo B. Crescentea, Fernando T. Silveiraab, Ralph Lainsonb, Claudia M.C. Gomesc, Márcia D. Laurentic, Carlos E.P. CorbettcCorresponding Author Informationemail address

Received 23 August 2007; received in revised form 17 June 2009; accepted 17 June 2009.

Summary 

The objectives of this study were to identify individuals with symptomatic and/or asymptomatic infection due to Leishmania (L.) infantum chagasi; to study the two types of infection, both clinically and immunologically, and to determine the prevalence rate of infection at the beginning of the study. This was a cross-sectional study with a cohort of 946 individuals, of both genders, from the age of 1 year, living in the municipality of Barcarena, PA, Brazil, an area endemic for American visceral leishmaniasis (AVL). The leishmanin skin test (LST) and the indirect fluorescent test (IFAT), were used for the diagnosis of infection. One hundred and twenty cases of infection were diagnosed, with a prevalence rate of 12.6%; eight cases showed high seroreactivity (1280–10240, IgG) in IFAT and no LST reaction; four of these cases were typical AVL and four had subclinical oligosymptomatic infection. Using two immunological methods with a clinical examination of the infected individuals enabled the identification of five clinical-immunological profiles which may promote a better understanding of the interaction between L. (L.) i. chagasi and the human immune response: asymptomatic infection (AI) 73.4%; subclinical resistant infection (SRI) 15%; subclinical oligosymptomatic infection (SOI) 3%; symptomatic infection (AVL) 3% and indeterminate initial infection (III) 5%.

a Tropical Medicine Institute, Pará Federal University, Belém, PA, Brazil

b Parasitology Department, Evandro Chagas Institute (Surveillance Secretary of Health, Ministry of Health), Belém, PA, Brazil

c Pathology Department, Faculty of Medicine, São Paulo University, Avenida Dr. Arnaldo, 455 – Sala 1215, CEP 01246-903, São Paulo, SP, Brazil

Corresponding Author InformationCorresponding author. Tel.: +55 11 3081 7799.

PII: S0035-9203(09)00206-5

doi:10.1016/j.trstmh.2009.06.010


View previous. 14 of 27 View next.